BLAIR WAGONER: Open Payments
NPI 1366220907 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 40 payments from 12 companies in 2025. Trend: 2023 $302 · 2024 $2,218 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $215 |
| Corium, LLC | 8 | $98 |
| E.R. Squibb & Sons, L.L.C. | 6 | $94 |
| Neurocrine BioSciences, Inc. | 3 | $88 |
| ABBVIE INC. | 4 | $88 |
| Alkermes, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
Products named: HETLIOZ, Azstarys, COBENFY, INGREZZA, VRAYLAR, ARISTADA, CAPLYTA, Jornay PM.
Industry payments across IN — which companies pay providers there.
